Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Ex vivo drug response heterogeneity reveals personalized therapeutic strategies for patients with multiple myeloma

Subjects: Clinic for Oncology and Hematology; Medical Clinic; 610 Medicine & health

  • Source: Kropivsek, Klara; Kachel, Paul; Goetze, Sandra; Wegmann, Rebekka; Festl, Yasmin; Severin, Yannik; Hale, Benjamin D; Mena, Julien; van Drogen, Audrey; Dietliker, Nadja; Tchinda, Joëlle; Wollscheid,

Record details

×
Academic Journal

Effector memory and central memory NY-ESO-1-specific re-directed T cells for treatment of multiple myeloma

Subjects: Clinic for Immunology; Institute of Pathology and Molecular Pathology; Epidemiology

  • Source: Schuberth, P C; Jakka, G; Jensen, S M; Wadle, A; Gautschi, F; Haley, D; Haile, S; Mischo, A; Held, G; Thiel, M; Tinguely, M; Bifulco, C B; Fox, B A; Renner, C; Petrausch, U (2013). Effector memory and

Record details

×
Academic Journal

Allo-SCT for multiple myeloma in the era of novel agents: a retrospective study on behalf of Swiss Blood SCT

Subjects: Clinic for Oncology and Hematology; 610 Medicine & health

  • Source: Gerull, S; Stern, M; Ben Aissa, A; Manz, M G; Schanz, U; Stussi, G; Chalandon, Y; Passweg, J; Mohty, B (2013). Allo-SCT for multiple

Record details

×
Academic Journal

MAGE-C1/CT7 spontaneously triggers a CD4+ T-cell response in multiple myeloma patients

Subjects: Institute of Experimental Immunology; Clinic for Oncology and Hematology; 570 Life sciences

  • Source: Nuber, Natko; Curioni-Fontecedro, Alessandra; Dannenmann, Stefanie R; Matter, C; von Boehmer, Lotta; Atanackovic, Djordje; Knuth, Alexander; van den Broek, Maries (2013). MAGE-C1/CT7 spontaneously

Record details

×
Academic Journal

MAGE-C1/CT7 is the dominant cancer-testis antigen targeted by humoral immune responses in patients with multiple myeloma

Subjects: Department of Biochemistry; Clinic for Oncology and Hematology; Institute of Pathology and Molecular Pathology

  • Source: Curioni-Fontecedro, A; Knights, A J; Tinguely, M; Nuber, N; Schneider, C; Thomson, C W; von Boehmer, Lisa; Bossart, W; Pahlich, S; Gehring, H; Moch, H; Renner, C; Knuth, A; Zippelius, A (2008).

Record details

×
Academic Journal

Melphalan dose in myeloma patients ≥65 years of age undergoing high-dose therapy and autologous stem cell transplantation: a multicentric observational registry study

Subjects: Clinic for Oncology and Hematology; 610 Medicine & health

  • Source: Ghilardi, Guido; Pabst, Thomas; Jeker, Barbara; Müller, Rouven; Cairoli, Anne; Müller, Antonia M S; Bargetzi, Mario; Hitz, Felicitas; Baldomero, Helen; Heim, Dominik; Schmidt, Adrian; Rossi, Davide;

Record details

×
Academic Journal

The Prospective Oral Mucositis Audit: relationship of severe oral mucositis with clinical and medical resource use outcomes in patients receiving high-dose melphalan or BEAM-conditioning chemotherapy and autologous SCT

Subjects: Epidemiology; Biostatistics and Prevention Institute (EBPI); 610 Medicine & health

  • Source: McCann, S; Schwenkglenks, M; Bacon, P; Einsele, H; D'Addio, A; Maertens, J; Niederwieser, D; Rabitsch, W; Roosaar, A; Ruutu, T; Schouten, H; Stone, R; Vorkurka, S; Quinn, B; Blijlevens, N (2009). The

Record details

×
  • 1-7 of  7 results for ""Multiple Myeloma""